Nasogastric/Orogastric Tube Placement Verification Study Using RightSpot pH Indicator to Verify Gastric Acidity

Status unconfirmed · Not applicable

Conditions studied: Small Bowel Obstruction, Gastrointestinal Hemorrhage

In brief

This study will evaluate the use of RightBio Metrics' RightSpot device used to determine if there is proper placement of a nasogastric or orogastric tube.

Key facts

Study ID

NCT01561729

Run by

RightBio Metrics

People needed

30

Starts

2012-01-01

Expected to finish

2014-12-01

Last updated by the study team

2014-11-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients 18 years and older
• Patient or proxy willing to provide informed consent
• Patients who require placement of a nasogastric/orogastric tube, in the ED or ICU, as standard of care, AND a member of the study staff is available and present for NG/OG tube placement.
• It is anticipated that the patient will remain in the ED/ICU in order to obtain RightSpot pH Indicator reading and verifying CXR

You may not qualify if…

• Patients less than 18 years of age
• Patient or proxy unwilling or unable to provide informed consent
• Patient with known or suspected pregnancy

Where it is running

• Tampa General Hospital — Tampa, Florida, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.